SCHEMBL31453609

SCHEMBL31453609

Cc1cc(NCCCN2CCCC2)ccc1F

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 1/20 0.48
▸ CYP2D6 P10635 1/20 0.48
▸ CYP2C19 P33261 1/20 0.48
▸ HRH3 Q9Y5N1 4/20 0.46
▸ CHRNA7 P36544 1/20 0.46
▸ KCNH2 Q12809 1/20 0.46
▸ BACE1 P56817 1/20 0.45
▸ MAPK1 P28482 2/20 0.43
▸ ALDH1A1 P00352 1/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ MBTD1 Q05BQ5 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ SCN5A Q14524 1/20 0.42
▸ EGFR P00533 1/20 0.41
▸ MAP3K8 P41279 1/20 0.41
▸ POLB P06746 1/20 0.41
▸ ATM Q13315 1/20 0.41
▸ HTR7 P34969 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31453612 0.86 MAPK1 (0.56) HRH3CHRNA7KCNH2BACE1MAPK1
SCHEMBL5929424 0.84 HRH3 (0.46) HRH3CHRNA7KCNH2BACE1MAPK1
Hydrochloric Acid SCHEMBL5929367 0.83 HRH3 (0.45) HRH3CHRNA7KCNH2BACE1MAPK1
SCHEMBL6840686 0.79 HRH3 (0.46) HRH3BACE1ALDH1A1EGFR
SCHEMBL5929350 0.79 KDM4E (0.51) HRH3ALDH1A1RAB9AL3MBTL1POLB
SCHEMBL18570641 0.78 HTR7 (0.44) CYP3A4HRH3BACE1MAPK1ALDH1A1
SCHEMBL5929421 0.75 ADRA2A (0.43) CYP3A4CYP2C19HRH3ALDH1A1
SCHEMBL31453546 0.74 ALDH1A1 (0.49) CYP3A4CYP2D6CYP2C19ALDH1A1
SCHEMBL5929366 0.74 SRC (0.45) ALDH1A1RAB9AHTR7
SCHEMBL6142477 0.73 ACHE (0.45) CYP3A4HRH3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025016138-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF SUZHOU EOC MEDICAL RESEARCH CO., LTD. (CN) 2025-01-23 — — WO disclosed
Send feedback